2 clinical trials found.
-
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients
The purpose of this research study is to investigate the effectiveness and safety of treatment with clazakizumab compared to a placebo (inactive substance) in kidney ...Phase
Interventional
TRIAL ROLE: Principal Investigator
-
A Randomized Open-Label Multi-Centre Active Control Study Investigating the Efficacy and Safety of Imlifidase in Eliminating Donor Specific Anti-HLA Antibodies in the Treatment of Active Antibody-Mediated Rejection in Kidney Transplant Patients
The purpose of this study is to assess the effectiveness and safety of the study drug, imlifidase in patients who qualify for the study and ...Phase
Interventional
TRIAL ROLE: Sub Investigator
